Country Profile at a Glance

Market Overview

Healthcare Infrastructure

Myanmar's public healthcare infrastructure is severely limited — approximately 1,000 public hospitals, many poorly equipped and understaffed, concentrated in Yangon and Mandalay. The private sector, centred on Yangon, provides the majority of quality healthcare for those who can afford it. Major private hospitals — Asia Royal Hospital, Parami General Hospital, and Pun Hlaing Siloam Hospital — operate at near-international standards and actively source international medical equipment. International development organisations (WHO, MSF, ICRC) also maintain significant medical equipment procurement in Myanmar.

Key Market Drivers

• Very low baseline healthcare infrastructure creating demand for all device categories
• Growing private hospital and clinic sector in Yangon actively sourcing quality equipment
• International development organisation procurement for humanitarian healthcare programmes
• High burden of infectious diseases (malaria, TB, dengue) sustaining diagnostic device demand
• Diaspora-funded private clinic investment growing in peri-urban areas
• Gradual recovery of pharmaceutical and medical supply chains creating distributor opportunities

Top Product Categories in Demand

Regulatory Environment

Framework & Authority

Medical devices in Myanmar are regulated by the Food and Drug Administration (FDA Myanmar) under the National Food and Drug Law 2018. Device registration is required for imported products. The registration process is relatively straightforward for products holding CE Mark or FDA clearance. A licensed Myanmar importer is required. FDA Myanmar registration typically takes 3–6 months. The political situation since 2021 has introduced additional complexity into regulatory processes — allow additional time and engage a local regulatory consultant with current in-country knowledge.

Key Registration Requirements

• FDA Myanmar device registration — CE Mark accepted as primary quality evidence
• Appointment of a licensed Myanmar importer/agent
• Burmese or English labelling acceptable
• Import duty: 0–5% for most medical devices
• Payment in USD strongly recommended; MMK contracts carry significant currency risk

Import & Trade Data

Myanmar imports nearly 100% of its medical devices. Thailand, Singapore, China, India, and Japan are the primary suppliers. Turkey's presence is minimal but there is clear demand for quality, competitively priced CE-certified products, particularly in the private hospital and NGO-procurement segments. Yangon-based distributors often also cover Cambodia and Laos.

Opportunities for Turkish Exporters

• Private hospital sector in Yangon: Asia Royal, Parami, and Pun Hlaing Siloam actively procure from international suppliers and can be approached through a Singapore or Thailand-based regional distributor
• NGO and development organisation procurement: UN agencies, MSF, and ICRC maintain large medical equipment procurement budgets in Myanmar — these organisations procure through international tender processes that CE-certified Turkish manufacturers can participate in
• Basic disposables at very low prices: Myanmar's critical shortage of disposables creates demand for competitively priced Turkish products
• Distributor-led market entry: engaging a Singapore or Bangkok-based regional distributor who already covers Myanmar removes the complexity of direct Myanmar market establishment

Challenges & Considerations

• Political risk: Myanmar's political situation since 2021 requires thorough due diligence; manufacturers should consult current government guidance on trade and sanctions compliance before entering the market
• Currency instability: the Myanmar Kyat has experienced severe devaluation; all commercial arrangements should be in USD
• Logistics challenges: supply chain disruptions affect delivery timelines; additional safety stock and flexible logistics planning are essential
• FDA Myanmar process unpredictability: regulatory timelines can be affected by administrative disruptions

Conclusion

Myanmar is a frontier market with real demand and real complexity. Turkish medical device exporters who approach it through an established regional distributor (Singapore or Bangkok-based), target the private hospital and NGO sectors, and manage political and currency risks carefully can access genuine procurement volumes. Direct market entry requires current, expert due diligence — but indirect entry through a regional partner with Myanmar coverage is a lower-risk path to this underserved market.